Abstract 4737: Saturation mutagenesis of FLT3-ITD: AC220-resistance-conferring kinase domain mutations are restricted to a limited number of residues and are cross-resistant to sorafenib in vitro.

Catherine C. Smith, Lauren Damon, Sara Salerno, Neil P. Shah. Abstract 4737: Saturation mutagenesis of FLT3-ITD: AC220-resistance-conferring kinase domain mutations are restricted to a limited number of residues and are cross-resistant to sorafenib in vitro. Experimental and Molecular Therapeutics. 2011 Apr 15; 4737-4737.

2011
https://researcherprofiles.org/profile/79293314

Catherine C. Smith, Lauren Damon, Sara Salerno, Neil P. Shah